Form 4: Director Evelyn Dilsaver Receives PACS Group RSU Grant

Director Evelyn Dilsaver was granted 4,660 restricted stock units in PACS Group, Inc. as part of an equity compensation arrangement.

Summary

• Director Evelyn S. Dilsaver acquired 4,660 restricted stock units (RSUs) of PACS Group, Inc. common stock.
• The transaction occurred on June 10, 2026.
• The RSUs were granted at a price of $0 per share.
• Following this transaction, the director's total beneficial ownership of common stock is 31,798 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting of RSUs is subject to the director's continued service to the issuer.

Future Outlook

The RSUs are scheduled to vest on June 10, 2027, or upon the date of the next annual meeting, provided the director remains in service.

Industry Context

StockSavvy.ai notes that this is a routine disclosure of director equity compensation, which is standard practice for publicly traded companies to incentivize board members.

Comparison to Industry Standards

• The grant of RSUs to non-employee directors is a standard corporate governance practice in the U.S. healthcare and services sector.
• The vesting schedule of one year is consistent with typical annual equity grant cycles for board members.

Stakeholder Impact

• Minimal impact on shareholders as this represents standard director compensation.

Next Steps

• Vesting of the 4,660 RSUs on June 10, 2027, or the next annual meeting date.

Key Dates

Keywords

PACS, PACS Group, Form 4, Insider Trading, Equity Compensation, Director Ownership